首页> 外国专利> METHOD FOR INHIBITION OF TERATOMA FORMATION BY SELECTIVELY INDUCED-APOPTOSIS OF HUMAN UNDIFFERENTIATED INDUCED PLURIPOTENT STEM CELLS

METHOD FOR INHIBITION OF TERATOMA FORMATION BY SELECTIVELY INDUCED-APOPTOSIS OF HUMAN UNDIFFERENTIATED INDUCED PLURIPOTENT STEM CELLS

机译:通过选择性诱导人未分化诱导多能干细胞凋亡抑制皮肤癌形成的方法

摘要

The present invention relates to a production method for induced-pluripotent-stem-cell-derived differentiated cells, from which undifferentiated induced pluripotent stem cells (iPS) have been eliminated, the method comprising the steps of: (a) preparing a cell sample comprising undifferentiated induced pluripotent stem cells and differentiated cells by differentiating induced pluripotent stem cells; and (b) selectively causing the death of the undifferentiated induced pluripotent stem cells by subjecting the product of step (a) to processing either with quercetin of formula 1 below or with YM-155 of formula 2 below. According to the present invention, the present invention makes it possible to effectively selectively cause the death only of undifferentiated induced pluripotent stem cells by causing induced pluripotent stem cells to differentiate into specific differentiated cells and then carrying out culturing in a differentiating culture medium comprising quercetin or YM-155, and, in the induced pluripotent stem cell differentiation method according to the present invention, only undifferentiated induced pluripotent stem cells that are a cause of teratoma formation are selectively caused to die, and thus differentiated differentiating cells are completely unaffected. In other words, the invention can be expected to ensure safety as the possibility of tumour formation during clinical use as a cell therapeutic agent is eliminated since the survival and functioning of the differentiated cells is maintained unchanged.
机译:本发明涉及用于诱导多能干细胞来源的分化细胞的生产方法,其中已经消除了未分化的诱导多能干细胞(iPS),该方法包括以下步骤:(a)制备包含未分化的诱导多能干细胞和分化的细胞通过分化诱导多能干细胞; (b)通过使步骤(a)的产物用下面的式1的槲皮素或下面的式2的YM-155处理,来选择性地引起未分化的诱导多能干细胞的死亡。根据本发明,通过使诱导的多能干细胞分化为特定的分化细胞,然后在包含槲皮素或YM-155,以及在根据本发明的诱导多能干细胞分化方法中,仅选择性导致致畸胎瘤形成的未分化诱导多能干细胞死亡,因此分化的分化细胞完全不受影响。换句话说,由于消除了分化细胞的存活和功能,因此消除了临床上用作细胞治疗剂的过程中肿瘤形成的可能性,因此可以期待本发明确保安全性。

著录项

  • 公开/公告号KR20140047545A

    专利类型

  • 公开/公告日2014-04-22

    原文格式PDF

  • 申请/专利权人 SOGANG UNIVERSITY RESEARCH FOUNDATION;

    申请/专利号KR20130121029

  • 发明设计人 CHA HYUK JIN;

    申请日2013-10-11

  • 分类号C12N5/074;C12N5/02;C07D311/00;

  • 国家 KR

  • 入库时间 2022-08-21 15:43:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号